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Abstract
Many Gram-negative bacteria use type III secretion systems to translocate effector proteins into host cells. These effectors
interfere with cellular functions in a highly regulated manner resulting in effects that are beneficial for the bacteria. The
pathogen Yersinia can resist phagocytosis by eukaryotic cells by translocating Yop effectors into the target cell cytoplasm.
This is called antiphagocytosis, and constitutes an important virulence feature of this pathogen since it allows survival in
immune cell rich lymphoid organs. We show here that the virulence protein YopK has a role in orchestrating effector
translocation necessary for productive antiphagocytosis. We present data showing that YopK influences Yop effector
translocation by modulating the ratio of the pore-forming proteins YopB and YopD in the target cell membrane. Further, we
show that YopK that can interact with the translocators, is exposed inside target cells and binds to the eukaryotic signaling
protein RACK1. This protein is engaged upon Y. pseudotuberculosis-mediated b1-integrin activation and localizes to
phagocytic cups. Cells with downregulated RACK1 levels are protected from antiphagocytosis. This resistance is not due to
altered levels of translocated antiphagocytic effectors, and cells with reduced levels of RACK1 are still sensitive to the later
occurring cytotoxic effect caused by the Yop effectors. Further, a yopK mutant unable to bind RACK1 shows an avirulent
phenotype during mouse infection, suggesting that RACK1 targeting by YopK is a requirement for virulence. Together, our
data imply that the local event of Yersinia-mediated antiphagocytosis involves a step where YopK, by binding RACK1,
ensures an immediate specific spatial delivery of antiphagocytic effectors leading to productive inhibition of phagocytosis.
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Introduction
The genus Yersinia contains three pathogenic species: Yersinia
pestis, Yersinia enterocolitica and Yersinia pseudotuberculosis [1]. Y. pestis,
the causative agent of plague, where bubonic plague is the most
common form, is usually transmitted by the bite of a flea and
spread to regional lymph nodes after which it can enter the
bloodstream and spread systemically [2]. It is believed that Y. pestis
replicate within macrophages during the early stages of infection at
peripheral host sites [3,4,5], while extracellular growth is
predominant during other stages of infection [6,7]. The entero-
pathogenic species Y. pseudotuberculosis and Y. enterocolitica are
transmitted by the oral-fecal route and penetrate the intestinal
epithelium and spread to the lymphatic system (first Peyer’s
patches and thereafter mesenteric lymph nodes) where they
replicate extracellularly [8,9]. Also enteropathogenic Yersinia
species can grow within macrophages [10], but if this occurs
during infection, like for Y. pestis, is still controversal. Common to
all three Yersinia species is their ability to replicate extracellularly in
lymphoid tissue where most other bacteria are effectively engulfed
and destroyed by phagocytes. Pathogenic Yersinia bind phagocytes
and can impair their phagocytic capacity as well as certain
inflammatory responses [11,12,13,14,15]. This permits bacterial
survival and subsequent dissemination from these sites, resulting in
systemic infection [16]. The capacity to survive and multiply in
lymphoid tissue and to inhibit several important host immune
mechanisms, including phagocytosis, is an essential virulence
property of this pathogen.
The capacity of these three pathogenic Yersinia strains to
multiply extracellularly and inhibit internalization by host cells
depends on a virulence plasmid that encodes a common type three
secretion system (T3SS) and virulence effectors such as the Yersinia
outer proteins (Yops). The Yops include YopH, YopE, YopJ,
YopM, YpkA, and YopK. Upon intimate contact with a target
cell, these effectors are induced in the bacterium and delivered into
the interacting host cell via a mechanism involving the plasmid
encoded T3SS [17]. Inside the target cell, the Yop effectors
interfere with several key mechanisms of the host immune defense
including phagocytosis, production of pro-inflammatory signaling
molecules, and activation of the adaptive immune system [18,19].
Intracellular growth is however not dependent on the virulence
plasmid [5]. Although most of the Yop effectors are necessary for
Yersinia virulence, the exact mechanism underlying their individual
roles is known only for a few [19]. For example, YopE is a Rho-
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YopH is a tyrosine phosphatase that disrupts host cell signaling
necessary for phagocytosis. This favours antiphagocytosis allowing
bacteria to preferentially replicate extracellularly [13,14,20,21,22].
YopD, along with YopB and LcrV, is required for translocation
of Yop effectors across the host cell plasma membrane. YopB and
YopD contain hydrophobic domains indicative of transmembrane
proteins and constituents of a pore [23,24]. It is assumed that the
Yop effectors pass through this pore when crossing the eukaryotic
target cell membrane. Interestingly, yopK mutants form a larger
pore and in line with this notion, yopK mutants overtranslocate
Yop effectors [24].
YopK is one of the least studied of the translocated Yop
effectors. This 21-kDa protein is found in all three of the human
pathogenic species (i.e., Y. pestis, Y. pseudotuberculosis, and Y.
enterocolitica (YopQ) [25,26,27], but it has no homologues in any
other bacteria that harbor a T3SS. YopK has been shown to
influence the size of the translocation pore [24] and is presumed to
play a role in regulation of Yop effector translocation [24,28]. This
is supported by observations that a yopK deletion mutant generated
larger pores and also over-delivered Yop effectors into target cells,
whereas a strain overexpressing YopK reduced their translocation
[24]. However, a Y. pseudotuberculosis yopK mutant was also avirulent
in orally infected mice; bacteria were cleared at the stage of Peyer’s
patches, and never caused signs of systemic infection [25,29].
Clearly therefore, YopK is essential for the ability of Y.
pseudotuberculosis to cause full disease, via a hitherto unknown
mechanism. Significantly, YopK is delivered into the target cell
[30], which suggests that YopK has an intracellular target. In a
recent report [31] it was suggested that YopK prevents
inflammasome activation by the T3SS. This conclusion was based
on the correlative observation that yopK mutants in contrast to
wild-type bacteria activated the inflammasome. However, this
observed response to infection with yopK mutants can equally well
be explained by larger pores allowing influx/efflux of ions such as
Ca
2+ and K
+ in addition to overtranslocation of effectors causing a
stress response that activates the inflammasome.
The aim of the present study was to elucidate a possible YopK
effector function inside the host cell. We identified the eukaryotic
signaling protein called receptor for activated C kinase (RACK1)
as a potential target of YopK. RACK1 is a cytosolic WD-40 repeat
protein that was originally identified as being bound to and
stabilizing the active form of protein kinase C (PKC) [32].
Additionally, RACK1 binds to b1-integrins [33,34,35], which also
function as Yersinia receptors on the target cell surface [36]. We
found that YopK is required for productive delivery of Yop
effectors and, together with an interaction with RACK1, is crucial
for Yersinia antiphagocytosis.
Results
YopK is associated with the translocation pore and is
exposed to the host cell cytoplasm
Infection of erythrocytes is commonly used to study Yersinia pore
formation. We have previously shown that hemolysis is induced to
a much greater extent by a yopK null mutant of Y. pseudotuberculosis
than by the corresponding isogenic wild-type strain [24]. The size
of the bacterial translocation pore is also increased in the absence
of YopK [24]. The Y. pseudotuberculosis translocation pore consists
of the two hydrophobic translocator proteins YopB and YopD,
which are inserted into the host cell membrane [37,38,39].
Interestingly, hemolytic assays in the presence of
35S-cysteine- or
35S-methionine followed by purification of red blood cell
membranes and subsequent autoradiography revealed that YopK,
together with YopB and YopD, was associated with the
erythrocyte membranes (Figure 1A, lanes 1–2). The presence of
these proteins, but not the other bacterial extracellular proteins
(LcrV and the adhesin Ail), in the membrane fraction was further
verified by Western blot analysis (Figure 1B and S1). Interestingly,
quantification analysis revealed that the yopK null mutant inserted
4.4 times more of YopB (p=0.04, n=5) and 2.5 times more of
YopD (p=0,086, n=5) in infected erythrocyte membranes
compared to the wild-type bacteria. This increase in membrane
associated translocators was not due to an increase in secretion, as
the yopK null mutant secreted YopB and YopD to similar levels as
the wild-type strain (data not shown). Importantly, the molar ratio
between the two translocators determined by autoradiography was
also altered: YopB/YopD was 0.71+/20.025 for the mutant strain
and 0.41+/20.03 for the isogenic wild-type strain (Figure 1A). In
addition, purification of a His-tagged YopD from bacterial
supernatants resulted in co-purification of YopK (Figure 1C),
and a reciprocal pull-down experiment using YopK–FLAG-coated
beads showed co-precipitation of YopD (Figure 1D), thus
confirming that YopK associates with the translocator proteins
[31]. Furthermore, our data indicate that presence of YopK
influences the pore composition where lack of YopK results in
increased amounts of membrane associated translocator proteins
resulting in a larger pore and as a consequence increased effector
translocation.
Given that YopK could associate with the translocation pore,
we also confirmed that it was exposed on the cytosolic side of the
host plasma membrane. To address this, we used a fluorescence
resonance energy transfer (FRET)-based b-lactamase reporter
assay that was developed to discriminate between extra- and
intracellularly localized T3SS effectors [40,41]. Expression
constructs encoding YopK–b-lactamase fusion proteins were
generated and introduced into yopK and yopB null mutant strains;
the latter strain was used as a translocation deficient control [23].
Using fluorescence microscopy we detected delivery of the YopK-
blac fusion protein into HeLa cells infected with a yopK null mutant
(Figure 1E, upper right), but we did not detect delivery of the
fusion protein into HeLa cells infected with the translocation-
deficient yopB mutant (Figure 1E, upper left).
YopK interacts with the host cell protein RACK1
Since YopK is indeed translocated, we next sought to identify a
eukaryotic target protein by using YopK as bait in a yeast two-
hybrid screen with a HeLa cell cDNA library. One of the positive
clones identified encoded for the C-terminal portion (aa 71–317) of
the scaffolding protein RACK1. This was particularly interesting
since RACK1 interacts with the cytoplasmic domain of b-integrins
[34] that serve as the receptors to which Y. pseudotuberculosis bind to
establish contact with eukaryotic cells [36]. To verify that the
YopK-RACK1 interaction observed in yeast also occurred in
HeLa cells (our established eukaryotic cell model system), we
performed pull down assays using an expression construct (YopK–
FLAG fusion) and HeLa cell lysates. In short, secreted YopK
protein was immobilized on beads, which were subsequently
incubated with HeLa cell lysate. Western blot analysis of YopK-
associated proteins revealed binding between RACK1 and YopK–
FLAG (Figure 2A). This confirmed that YopK can interact with
RACK1 in the eukaryotic cytosol, suggesting that this interaction
is biologically relevant. To further explore the observed RACK1-
YopK interaction, we performed additional pull down experi-
ments, now using recombinant GST-RACK1 and supernatant
from a multi-Yop mutant strain (unable to express YopE, YopH,
YopM, YopB, YopD) expressing YopK. In brief, recombinant
GST-RACK1 was immobilized on glutathione sepharose beads
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containing YopK. Western blot analysis of RACK1-associated
proteins revealed binding between YopK and RACK1 (Figure 2B),
thus indicating that the binding of YopK to RACK1 is direct, and
not mediated by a bridging eukaryotic molecule.
To characterize the functional role of this interaction, we used
the yeast two-hybrid system to map the respective interactive
domains within both RACK1 and YopK. RACK1 forms a
propeller-like structure that contains seven ‘‘blades’’ (domains 1 to
7), which consist of WD40 repeats that can bind to different
ligands [42]. In our analysis, domains 5 and 6 of RACK1 proved
to be sufficient for YopK binding (Figure S2A). Similarly, we
generated and expressed different regions of YopK in the yeast
system. This established that residues 30–59 were important for
Figure 1. YopK interacts with translocation machinery components and is exposed inside target cells. (A) Autoradiogram showing
presence of YopB, YopD, and YopK in purified membranes from erythrocytes infected with wild-type and isogenic mutants of Y. pseudotuberculosis
labeled with
35S-methionine and
35S-cysteine. (B) Western blot showing YopB, YopD, and YopK in purified membranes from erythrocytes infected
with wild-type and isogenic mutants of Y. pseudotuberculosis. The membrane fractions were separated on a 12% SDS page followed by Western blot
analysis with antibodies raised against YopB, YopD and YopK. (C) Co-purification of YopD and YopK. His-YopD was purified from culture supernatants
of a Y. pseudotuberculosis multiple yop mutant strain expressing His-YopD [YPIII(pIB29MEKByopD::His)]. Co-purification of YopK was detected by
Western blot using antibodies against YopK. Detection of YopD by anti-YopD antisera was performed as a control. (D) Co-immunoprecipitation of
YopK and YopD. Anti-FLAG beads were incubated with culture supernatants of a Y. pseudotuberculosis yopK mutant strain expressing YopK-FLAG in
trans. Co-immunoprecipitation of YopD was detected by Western blot using antibodies against YopD. Detection of YopK by anti-YopK antisera was
performed as a control. (E) Translocation of YopK–blac and YopK
AA–blac into eukaryotic cells. HeLa cells were infected with the indicated Y.
pseudotuberculosis strains, after which the FRET-based fluorescent b-lactamase substrate CCF2 was added and the samples were analyzed by
fluorescence microscopy. The translocation-deficient yopB null mutant strain was used as negative control. Green cells indicate that no translocation
occurred, whereas blue cells show that Yop–blac fusion proteins were delivered into the HeLa cells. The percentage of blue cells, indicating
translocation of YopK–blac, was: 70+/23.5% in the yopK mutant and 0% in the yopB mutant. The percentage of blue cells, indicating translocation of
YopK
AA–blac, was: 58+/25.2% in the yopK mutant and 0% in the yopB mutant. Data is presented as mean +/2 SEM of at least six independent
experiments.
doi:10.1371/journal.pone.0016784.g001
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interaction, we performed a pair-wise alanine scan of the RACK1-
binding region in YopK. This revealed that amino acids 45 and 46
in YopK were essential for binding to RACK1 (Figure 2C). Thus,
we introduced these two amino acid changes (T45A, D46A) into
the yopK gene in cis on the virulence plasmid pIB102 of Y.
pseudotuberculosis, which resulted in the mutant strain YPIII(pIB156)
(Table 1), hereafter denoted yopK
AA. Phenotypic characterization
Figure 2. YopK interacts with RACK1 and this interaction is important for virulence. (A) Co-immunoprecipitation of YopK and RACK1.
Beads with YopK-FLAG or control beads were incubated with HeLa cell lysates. Co-immunoprecipitation of RACK1 was detected by Western blot with
anti-RACK1 antibodies. Detection of YopK by anti-YopK antisera was performed as a control, and HeLa cell lysate (12.5% input) was loaded for
comparison. (B) Co-precipitation of purified recombinant RACK1 and YopK. Recombinant GST and GST-RACK1 on beads were incubated with culture
supernatants of a Y. pseudotuberculosis multiple yop mutant strain expressing YopK-FLAG in trans [YPIII(pIB29MEKBD, pAH11)]. Co-precipitation of
YopK was detected by Western blot with anti-YopK antibodies. Detection of RACK1 by anti-RACK1 antisera was performed as a control, and the
bacterial culture supernatant (12.5% input) was loaded for comparison. (C) Pairwise alanine scan of YopK using the yeast two-hybrid assay as a read
out. Interaction between the YopK variants and RACK1 was determined as growth of yeast on selective plates. In the diagram, +++ indicates growth
corresponding to that seen in strains with non-mutated YopK and RACK1, and – stands for no growth. The mutated sequence is indicated in green
and the amino acids identified as important for the interaction are in red. (D) Real-time monitoring of Y. pseudotuberculosis infection using the IVISH
technique. Mice were orally infected with 5.2610
8, 4.9610
8, and 6.3610
8 bacteria for the wild-type, yopK, and yopK
AA strains respectively, and
bioluminescent signals from the infected animals were plotted. Data are presented as photons/sec on the indicated days post infection, and the
illustrated values represent mean 6 sd for the five mice in each group. Data were compared by student’s paired t-test, differences being considered
significant at P,0.1. (E) Bioluminescent image of one representative mouse for each bacterial strain on days 3 and 13 post infection. The color bar
presents the total number of emitted photons, with high and low bioluminescent signals indicated by red and blue, respectively.
doi:10.1371/journal.pone.0016784.g002
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key respects [24,25]. Both strains maintained normal control of
Yop expression and Yop secretion in vitro (data not shown) and the
protease protection assay revealed that both strains translocated
increased levels of Yop effectors into HeLa cells (Figure S2C).
Further, YopK
AA was detected together with YopD and YopB in
the plasma membrane of infected erythrocytes (Figure 1A, lane 3)
and located to the cytosolic side of the HeLa cell membrane
(Figure 1D, bottom left and right). Moreover, similar to the yopK
mutant (described above), infection with the YopK
AA-expressing
strain also resulted in larger amounts of especially the translocator
YopB (1.5 times more) in the target cell membrane resulting in an
altered YopB/YopD ratio (0.52+/20.04) compared to that seen
with the wild-type strain (0.41+/20.03). The observed effect on
the translocator amount and ratio was however less prominent
than that seen with the yopK mutant, which likely depends on
presence of the mutated YopK
AA.
To gain further insight into the importance of YopK and the
interaction with RACK1 for Y. pseudotuberculosis virulence, we took
advantage of the new in vivo imaging system technology that allows
real-time monitoring of Yersinia infections [43]. The yopK deletion
and yopK
AA substitution were introduced into the bioluminescent Y.
pseudotuberculosis wild-type strain YPIII(pCD1 Xen4). Female
BALB/c mice were orally infected with 5.2610
8, 4.9610
8, and
6.3610
8 bacteria for the wild-type, yopK, and yopK
AA strains,
respectively. During the course of infection, mice were visualized
daily and analyzed for bioluminescence on days 3, 8, 10, and 13.
All mice infected with wild-type bacteria showed clear signs of
disease (ruffled fur and diarrhea) on days 4–6, whereas mice
infected with either of the yopK mutant strains were apparently
healthy. Analysis of total light emitted from the infected mice
revealed that all were similarly colonized by the three Yersinia
strains during the first eight days. Thereafter, the signals from mice
infected with either of the two yopK mutant strains declined, while
signals from animals infected with the wild-type strain remained
constant (Figures 2D and 2E), showing a significant difference
between the signals from mice infected with the wild-type strain
compared to the two yopK mutants. Thus, the two yopK mutants are
similarly also attenuated during mouse infection.
Yersinia antiphagocytosis requires RACK1
RACK1 is a ubiquitously expressed protein that interacts with a
large array of signaling molecules, regulating cellular functions
such as adhesion, movement, and division [42]. In particular,
RACK1 interacts with the cytoplasmic domain of b1-integrins
[34] and was also recently reported to bind focal adhesion kinase
and participate in signaling from adhesion receptors [44]. Given
that b1-integrins constitute the eukaryotic cell receptors to which
Yersinia pseudotuberculosis docks via its adhesin invasion [36], perhaps
RACK1 participates in the bacterium-induced b1-integrin-medi-
ated events. This idea was appealing because it could also mean
that YopK binds to RACK1 to directly interfere with a signaling
pathway that is important for host cell defense against the
pathogen. To test this idea, we exposed HeLa cells to lentivirus-
mediated RNAi of RACK1 to generate stable cell lines with
downregulated RACK1 expression. A stable clone with 85%
reduction of RACK1 expression (Figure 3A) (hereafter denoted
RACK1 RNAi cells) was selected for further investigation.
An essential virulence feature of both enteropathogenic
yersiniae and Y. pestis is the ability to block phagocytic uptake to
Table 1. Y. pseudotuberculosis strains and plasmids used in this study.
Strain Relevant genotype Source or Reference
Yersinia pseudotuberculosis
YPIII Virulence plasmid cured [76]
YPIII(pIB102) yadA,K m
R (wild-type) [62]
YPIII(pIB155) yadA, yopK,K m
R [25]
YPIII(pIB156) yadA, yopK T45A, D46A,K m
R This study
YPIII(pIB526) yadA, yopE, Km
R [28]
YPIII(pIB604) yadA, yopB,K m
R [23]
YPIII(pIB621) yadA, yopD, Km
R [66]
YPIII(pIB29MEKB) yadA, yopH, yopM, yopE, yopK, yopB, ypkA,K m
R [23]
YPIII(pIB29MEKBD) yadA, yopH, yopM, yopE, yopK, yopB, yopD, ypkA, Km
R This study
YPIII(pIB29MEKByopD::His) yadA, yopH, yopM, yopE, yopK, yopB, ypkA, yopD::his,K m
R This study
YPIII(pCD1, Xen4) Tn1000::Tn5 luxCDABE, Km
R Caliper Life Sciences
YPIII(pCD155, Xen4) Tn1000::Tn5 luxCDABE, yopK,K m
R This study
YPIII(pCD156, Xen4) Tn1000::Tn5 luxCDABE, yopKT45A, D46A,K m
R This study
Plasmids
pAH3 yopK
+, Amp
R [25]
pTS103 exoS
+, Amp
R [77]
pYopK-blac yopK-blac
+, Cml
R This study
pYopK
AA-blac yopK-blac
+, Cml
R This study
pAH11 yopK-Flag
+, Amp
R (A. Holmstrom, unpublished)
pMF115 yopK
+, Amp
R This study
pGEX-RACK1 Gst-Rack1
+, Amp
R This study
doi:10.1371/journal.pone.0016784.t001
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internalization of the bacteria by eukaryotic cells has been
demonstrated using professional phagocytes and was initially
designated antiphagocytosis [11,13,15,45]. Since the underlying
mechanism of inhibition of internalization is similar in phagocytes
and HeLa cells, the term antiphagocytosis is hereafter used for
defining inhibition of bacterial internalization by both cell types
(the term does not include the virulence plasmid independent
avoidance of intracellular killing [4]). Non-opsonised Y. pseudotu-
berculosis is mainly internalized via the invasin-b1-integrin
interaction in both these cell types [36,45,46,47]. To ascertain
whether RACK1 is involved in phagocytosis of Y. pseudotuberculosis
or if it interferes with antiphagocytosis, we performed infection
experiments using RACK1 RNAi cells and determined the
amount of extracellular and intracellular bacteria. In agreement
with previously reported results [13], the plasmid-cured avirulent
Y. pseudotuberculosis strain YPIII was efficiently internalized by
control HeLa cells (69% internalization) (Figure 3B), whereas the
corresponding wild-type strain remained largely extracellular
(11% internalization) (Figure 3B). Furthermore, the avirulent
YPIII strain was still efficiently phagocytosed by the RACK1
RNAi cells (64% compared to 69% internalization by the HeLa
control cells) (Figure 3B). Hence, eukaryotic cells do not require
RACK1 to internalize Yersinia. Surprisingly, the virulent wild-type
strain displayed a significant reduction in the ability to block
phagocytosis by RACK1 RNAi cells (43% internalization)
(Figure 3B). Analyses of bacterial adherence by counting total
number of cell-associated bacteria revealed that the bacteria
adhered to the RACK1 RNAi cells to similar extent as to the
control cells. This implies that in the absence of RACK1,
eukaryotic cells are protected from the Yersinia antiphagocytic
attack. Notably, the absence of RACK1 could not protect RACK
RNAi cells from antiphagocytosis induced by the yopK null mutant
or the yopK
AA mutant (Figure 3B and data not shown). In contrast,
RACK1 RNAi cells were resistant towards the antiphagocytic
activity of a trans-complemented yopK null mutant (Figure 3B).
While this might mean that YopK itself is an effector protein
directly involved in the antiphagocytic mechanism, we could not
find any evidence in support of this. Isogenic yopK
+ and yopK
2
mutants (both unable to express YopH, YopE, YopM, and YpkA)
were indistinguishable from each other with respect to their ability
to block phagocytosis in HeLa cells that were or were not
expressing RACK1 (data not shown). Since YopK and RACK1
interact, a plausible interpretation of these surprising findings is
that in the absence of RACK1, YopK has a negative impact on
translocation control, either at the level of effector delivery or
effector targeting.
To confirm that the reduced antiphagocytic effect on RACK1
RNAi cells was actually due to the presence of lower levels of
RACK1, and not an indirect effect of clonal selection or the RNAi
procedure itself, we analyzed an additional RACK1 RNAi cell line
with approximately similar level of RACK1 downregulation, but
obtained with an oligo directed to another target sequence. Also
this RACK1 RNAi cell line was resistant towards antiphagocytosis
(Fig S3A), thus excluding an eventual off-target effect. In addition,
we included two other RACK1 RNAi cell lines in the analysis; one
that displayed 60% downregulation of RACK1, while the second
was not downregulated at all. Similar levels of antiphagocytosis
were achieved by the wild-type strain in the cell line with
undetectable RACK1 downregulation and the control HeLa cells
(Figure S3B). On the other hand, the extent of antiphagocytic
activity was intermediate in the cells with 60% RACK1
downregulation compared to the level in cells with 85%
downregulation (Figure S3B). Thus, there was a direct dose-
response correlation between the level of bacterial phagocytosis
and the amount of RACK1. Hence, together these experiments
show that the observed reduction in antiphagocytosis is linked to
low levels of RACK1 in the target cells.
Translocation of Yop effectors does not require RACK1
To determine whether the level of RACK1 influences the
amount of Yop effectors translocated, we employed two different
methods to analyze T3SS-mediated translocation of effectors into
eukaryotic cells: a translocation assay using the Pseudomonas
aeruginosa effector ExoS [48] and the protease protection assay
[49]. In the former technique, the ExoS-dependent ADP
ribosylation of cytoplasmic proteins (e.g., Ras) allows sensitive
detection of ExoS translocation into eukaryotic cells. We used the
Figure 3. RACK1 is required for antiphagocytosis. (A) Downregulation of RACK1 protein expression in HeLa cells by RNAi. Lysates of control
and RACK1 RNAi HeLa cells analyzed by Western blot using anti-RACK1 antibodies. Levels of RACK1 protein are presented as expression relative to
that in HeLa control cells. (B) Internalization of the indicated Y. pseudotuberculosis strains by control and RACK1 RNAi HeLa cells. The number of
bacteria internalized is presented as percent of the total number associated with HeLa cells. The illustrated data represent mean 6 SEM of at least
three independent experiments (P,0.05 *).
doi:10.1371/journal.pone.0016784.g003
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(Table 1) to infect control and RACK1 RNAi HeLa cells. Lysates
were analyzed by Western blot to detect modification of Ras. Both
cell lines displayed comparable levels of Ras modification,
indicating that similar amounts of ExoS were translocated into
the different cells (Figure 4A). This agreed with the results of the
protease protection assay where similar levels of the antiphagocytic
effector YopE were translocated into the two cell types (Figure 4B).
Collectively, this implies that RACK1 does not affect the level of
Yop effector translocation per se. Consequently, the reduced
antiphagocytic capacity of Y. pseudotuberculosis in contact with
RACK1 RNAi cells cannot be explained by altered levels of
antiphagocytic effectors inside these cells.
Yersinia-mediated cytotoxicity does not require RACK1
Secondary to antiphagocytosis, prolonged infection of adherent
cells induces cell rounding, which is often followed by detachment
from the underlying substratum. This is due to YopE-mediated
disruption of F-actin organization, an effect that is referred to as
cytotoxicity [50]. This cytotoxicity assay is often employed to
evaluate the general effects of Yop effector function. We used the
assay here to determine whether the YopK–RACK1 interaction is
important also for this late and more devastating impact of
prolonged exposure to the antiphagocytic effectors. Interestingly,
the RACK1 RNAi cells and the control HeLa cells were equally
affected by the cytotoxic capacity of the Y. pseudotuberculosis wild-
type strain and also by the yopK null and yopK
AA mutant strains
(Table 2). Hence, the absence of RACK1, which protects cells
from the immediate effects of antiphagocytosis, does not protect
against the late onset global cytotoxic effects mediated by
prolonged exposure to the bacteria. This shows that the YopK–
RACK1 interaction is exclusively needed for the immediate local
effect in close proximity to the bacterial attachment site, which
represents the inhibitory influence of antiphagocytic effectors.
RACK1 localizes to phagocytic cups
Our finding that the RACK1–YopK interaction is a local event
selectively important for antiphagocytosis prompted us to
investigate the involvement of RACK1 in host cell signaling
induced by cell surface binding of the bacteria. Upon infection, Y.
pseudotuberculosis bind to, cluster, and activate b1-integrins [36],
resulting in internalization of the bacteria in the absence of Yop
effectors. Given that RACK1 interacts with the cytoplasmic part of
b1-integrins and with associated signaling proteins [34,44] it could
possibly participate in signaling mechanisms activated by the
bacterial binding. To test this, we analyzed the subcellular
localization of RACK1 during b1-integrin-mediated cell spread-
ing. In the spreading assay, cells were detached and allowed to rest
before exposure to a surface coated with Y. pseudotuberculosis invasin
encompassing the b1-integrin-binding region [51]. Interestingly,
while RACK1 was localized to the perinuclear area in routinely
cultured HeLa cells (Figure S4), a fraction of RACK1 was
transiently recruited to the cell edges during b1-integrin stimulated
cell spreading (Figure 5A). This was most prominent after 30 min
incubation on the invasin-coated surface, by which time most of
the cells had started to spread. Thus, RACK1 is recruited to areas
of b1-integrin activation during initial spreading, which suggests
that RACK1 participates in the early events of b1-integrin
signaling. This is in agreement with a previous study suggesting
that RACK1 can control initiation of cell spreading [44].
Consequently, it is likely that an interaction between the
bacterium and the host cell induces a corresponding recruitment
of RACK1 to the bacterial binding site. To test this, we performed
immunofluorescence analysis to visualize the localization of
RACK1 in HeLa cells internalizing Y. pseudotuberculosis. In support
of our hypothesis, RACK1 was found in association with
phagocytic cups, where the bacteria were partially surrounded
by the HeLa cell membrane (Figure 5B). This implies that RACK1
is engaged during b1-integrin-mediated internalization of Yersinia,
and is recruited to intracellular areas that are near an
extracellularly located bacterium. Together with our data showing
that YopK is connected to the translocation complex and exposed
on the cytosolic side of the host cell plasma membrane, the data
collectively strengthen our hypothesis that YopK targets RACK1
in the host cell.
Discussion
Pathogenic Yersinia species utilize a powerful T3SS to deliver
effector proteins into the interior of the targeted host cells [17]. A
set of translocator proteins form a pore in the host cell membrane
through which these effectors are thought to gain access into the
host cell cytosol. This virulence mechanism allows these bacteria
to purposefully block innate immune cell defense mechanisms such
as phagocytosis so they can proliferate in lymphatic tissue [13].
Figure 4. RACK1 is not required for Yop translocation. (A) Translocation of ExoS resulting in modification of Ras in control and RACK1 RNAi
HeLa cells. The cells were infected with a Y. pseudotuberculosis strain expressing ExoS [YPIII(pIB526), pTS103]. Modification of Ras was visualized by
Western blot with anti-Ras antibodies. Detection of tubulin was used as loading control. (B) Translocation of YopE into control and RACK1 RNAi HeLa
cells. Cells were infected with the indicated strains and then treated with proteinase K. Thereafter, the cells were lysed with digitonin or left untreated.
The resulting supernatants were subjected to Western blot analysis using anti-YopE antisera. The translocation deficient yopD mutant was included as
negative control and detection of Erk was used as loading control.
doi:10.1371/journal.pone.0016784.g004
RACK1 Interacts with Yersinia Virulence
PLoS ONE | www.plosone.org 7 February 2011 | Volume 6 | Issue 2 | e16784However, the phagocytic process is initiated as soon as a
bacterium comes in contact with a target cell and completed
within minutes after cell contact. Therefore, it is assumed that
pathogenic Yersinia battle to impair this process via a very rapid
and precise mechanism for effector delivery and action. In line
with this, we have previously shown that Yop effector deployment
and intracellular activity can be measured within 30 seconds after
the bacterium makes contact with a host cell [45,52]. Nevertheless,
extreme rapidity alone would not be sufficient; individual Yops
would also need targeting to the precise site of action. Regulation
of this process in the bacterium occurs on several levels; this
includes coordinating target cell contact with induction of gene
expression [53], subsequent feed-back repression [28], and via
control of effector translocation [24]. We have presented data in
this study to support a mechanism that guarantees productive
antiphagocytic effector translocation leading to an instant blockage
of phagocytosis. It relies upon an interaction in the host cell
between YopK, which is associated with the pore complex, and
the eukaryotic protein RACK1.
We observed that RACK1 was specifically required for
antiphagocytosis. This was based on the finding that host cells
downregulated for RACK1 expression engulfed the pathogen to a
much greater extent compared to cells with normal RACK1
expression, implying that these RACK1 RNAi cells are resistant to
the antiphagocytic activity of the T3SS. This was quite
unexpected; making it the first reported cell line to be impervious
to the action of the Yersinia antiphagocytic machinery. Important-
ly, virulence effectors were translocated to the same extent into
cells regardless of their RACK1 expression level and these
intracellular effectors still induced a normal cytotoxic response in
both cell lines. This means two things; firstly, translocation of
effectors and the process of cytotoxicity induction do not require
RACK1, and secondly, antiphagocytosis and cytotoxicity are
clearly two distinct events during cell infection. Another striking
feature was that the ability of the pathogen to mediate
antiphagocytosis towards RACK1 RNAi cells diminished signif-
icantly when YopK was present. Notably, this failure to inactivate
the critical cellular targets and interrupt phagocytosis occurred
despite efficient antiphagocytic Yop effector translocation into the
target cells. Hence, the discrepancy between Yersinia YopK
+
bacteria inducing an uncompromising cytotoxic response on the
one hand, but failing to establish antiphagocytosis on the other,
suggests that the latter process requires specific features of the
effector translocation process that are overseen by YopK. This
agrees with our previous results concerning the antiphagocytic
effector and major cytotoxin YopE [54]; certain yopE point
mutants exhibited attenuated virulence but still gave rise to
cytotoxicity in HeLa cells. Thus, the cytotoxic effect is actually a
secondary event that occurs only after prolonged infection and is
dispensable for in vivo virulence. On the other hand, there appears
to be a direct correlation between the ability of Y. pseudotuberculosis
to resist phagocytosis and to cause systemic infections in mice. This
is based on the fact that except translocation-deregulated yopK
mutants, no other attenuated Yop effector mutant possesses full
antiphagocytic capacity. In fact, mutants defective in antiphago-
cytosis are cleared at the initial stage of infection in Peyer’s patches
and mesenteric lymph nodes [25,29].
YopK and antiphagocytosis are inextricably linked. For several
years, YopK has been suspected to affect the Yop translocation
pore [24]. Herein, we show that YopK localized with the
translocators YopB and YopD in the membrane fraction of
infected cells. In addition, YopK can be found inside infected host
cells – presumably at the zone of bacteria-host cell contact.
Interestingly, we observed that RACK1 also accumulates at the
site of bacterial attachment to host cells and immediately upon
activation of b1-integrins. We believe that this RACK1 localiza-
Table 2. Yersinia mediated cytotoxicity does not require
RACK1.
Strain
Cytotoxicity in HeLa
control cells
Cytotoxicity in RACK1
RNAi cells
avirulent 22
wt ++ ++
yopK +++ +++
yopK
AA +++ +++
doi:10.1371/journal.pone.0016784.t002
Figure 5. RACK1 localizes to phagocytic cups in infected HeLa cells. (A) RACK1 is recruited to the edges of HeLa cells upon b1-integrin
activation. HeLa cells were allowed to spread on coverslips coated with the b1-integrin ligand invasin. At indicated time points, cells were fixed,
stained for RACK1, and analyzed by immunofluorescence microscopy. The number of cells with RACK1 localized in the edges is presented as percent
of the total number of cells. The data represent mean 6 SEM of at least three independent experiments. The inset shows a representative cell at
30 min. (B) Localization of RACK1 in HeLa cells during infection with Y. pseudotuberculosis. HeLa cells were infected for 5 minutes, fixed and stained
for RACK1 (green) and Yersinia (red). The samples were analyzed by confocal microscopy.
doi:10.1371/journal.pone.0016784.g005
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such a location would enable RACK1 to interact with YopK
associated with the T3SS. Indeed, using independent protein-
protein binding assays, we could demonstrate this interaction.
Together, these data suggest that YopK functions as a sensor and
mediatorofproductive effectortranslocation.Thus,itisfeasiblethat
the YopK-RACK1 binding contributes to efficient antiphagocytosis
where the association of YopK with the translocation pore ensures
that translocated effector proteins are immediately exposed to their
key target(s) represented by signaling proteins involved in b1-
integrin-mediated internalization. Interesting in this context is that
RACK1, located at peripheral initial adhesion structures, has been
shown to bind to focal adhesion kinase [44], which constitutes a
target of the antiphagocytic effector YopH [55].
From this work, we suggest that RACK1 serves as a recognition
site for YopK to obtain a precise spatial translocation of
antiphagocytic effectors allowing instant targeting of the phagocytic
machinery. At first glance however, this might be difficult to
reconcile considering that antiphagocytosis works fine in the
absence of YopK, or both YopK and RACK1, but not in the
absence of RACK1. In this respect, consider the critical finding that
RACK1 RNAi cells resist the antiphagocytic effect of wild type Y.
pseudotuberculosis, but not of the yopK mutants. Thus, the key to
unlocking this conundrum is to understand how yopK mutants
suppress the RACK1 minus phenotype. The most likely reason for
this is that these mutants show an overtranslocation phenotype,
resulting in excessive delivery of Yop effectors into the host cell [24].
Although effector delivery in the absence of YopK would be
random and unorganized, their shear excess inside the cell will
ensure that they still find and inactivate the critical target(s) within
the necessary time-frame. Therefore, this excess of effectors would
overcome any need for YopK-RACK1 recognition; after all, only in
the presence of YopK is RACK1 required for antiphagocytosis!
Consistent with this is the avirulent phenotype of yopK mutants;
surplus delivery of effectors is clearly detrimental for bacterial
survival in vivo. The yopK mutants were cleared after a week of
infection, likely as a consequence of damaging effects on host cells
resulting in increased recruitment of immune cells and/or
inundating the host with antigenic epitopes against which it can
trigger a more robust and effective immune response. These
mutants might also display reduced in vivo fitness because of the high
energetic cost associated with Yop effector over-translocation.
Whatever the reason(s), it suggests that RACK1 targeting by YopK
is a key step in the controlled, target-directed process of effector
delivery and a requirement for virulence. Antiphagocytosis by
Yersinia is immediate, which contrasts to other pathogenic bacteria
harboring a T3SS such as Enteropathogenic E. coli (EPEC) and
Enterohemorrhagic E. coli (EHEC) that can induce an antiphago-
cytosis-like response after prolonged bacteria-host cell exposure
[56,57,58,59]. Since YopK is unique to the Yersinia T3SS, we argue
that its interaction with RACK1 forms the basis for the immediate
blocking of phagocytosis, a hallmark of this pathogen. We suggest
that this also applies for Y. pestis during the extracellular stages of
infection. Y. pestis do not express a functional invasin, but the
adhesins Ail and Pla bind the extracellular matrix protein
fibronectin that can interact with b1-integrins [60]. This pathogen
that is more virulent than the enteropathogenic strains and exhibits
an extremely efficient growth in lymph nodes during late phases of
infection is also equipped with an antiphagocytic capsule, which
likely contributes [15,61]. Taken together, based on our data, we
suggest a hypothetical model of this YopK-RACK1 interplay that
would account for the ability of Yersinia to cause an instant
phagocytic block (Figure 6). In this model, antiphagocytosis involves
action at a distance from the bacterial surface where YopK ensures
specific spatial delivery of antiphagocytic effectors using RACK1 as
a marker for an active phagocytic signaling machinery.
Materials and Methods
Ethics Statement
Mice were housed under standard conditions and were given
food and water ad libitum. The experiment was approved (Dnr
A81-08) by, and performed according to the guidelines of, the
Umea ˚ University Animal Ethics Committee.
Bacterial strains and growth conditions
This study was conducted using wild-type Y. pseudotuberculosis
YPIII(pIB102) [62] harboring the 70 kb virulence plasmid and
Figure 6. Hypothetical model illustrating how Y. pseudotubercu-
losis utilizes RACK1 for productive translocation resulting in
anti-phagocytosis. Upon host cell contact, bacterial binding to b1-
integrins causes clustering and activation of this receptor. This leads to
engagement ofsignalingproteinsinthehostcell,includingRACK1thatis
recruited to the zone of bacteria-host cell contact. At this site of action,
RACK1 functions as a marker for an activated phagocytic signaling
machinery that is specifically recognized by YopK. Binding of RACK1 by
YopK orchestrates correct temporal and spatial programming of Yop
delivery to concentrate internalized antiphagocytic effectors at the ‘‘right
place’’ where they instantly can bind to and inactivate their protein
target(s). This permits Yersinia to rapidly neutralize the very early signals
originating from activated receptors and thereby ensure instant
impairment of the phagocytic process. In the absence of RACK1 (RACK1
RNAi cells), the spatial control of effector translocation is lost resulting in
aimless Yop delivery. This diminishes a critical effector concentration in
the zone of bacteria-host cell contact that would normally be needed to
effectively negate phagocytic signaling. This leads to a non-productive
interaction between the pathogen and the target cell that terminates in
bacterial engulfment. In the absence of YopK (yopK mutant) the
translocation of Yops is deregulated resulting in excessive delivery of
Yop effectors. Thus, although Yop effector delivery would be aimless due
to the absence of the YopK-RACK1 interaction, the over-supply of
available Yops ending up inside the target cell will ensure that a critical
concentration necessary to dismantle phagocytic targets within the host
cell would still be reached. However, still yopK mutants are avirulent,
indicating that surplus delivery of effectors is clearly detrimental for
bacterial survival in vivo.
doi:10.1371/journal.pone.0016784.g006
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experiments, bacteria were grown overnight at 26uC in Luria-
Bertani broth (LB), TMH, or Brain Heart Infusion (BHI)
supplemented with 5 mM EGTA and 20 mM MgCl2. To induce
Yop expression, the bacteria were diluted in LB, TMH, BHI, or
antibiotic-free cell culture medium and grown at 26uC for 30 min
and subsequently at 37uC for 1–3 hr.
Plasmid construction
To generate the YopK–GAL4-BD fusion construct pMF115,
the yopK gene from the Y. pseudotuberculosis virulence plasmid
pIB102 was amplified by PCR and cloned into the EcoRI/PstI
sites of the yeast plasmid pGBT9 (Clontech Laboratories Inc). The
yopK–Flag expression vector was obtained by constructing an in-
frame carboxy-terminal fusion of YopK, and the eight-amino-acid
FLAG epitope DYKDDDDK [63] by PCR amplification using
the virulence plasmid pIB1 as template. The 972-bp fragment that
contained the yopK gene with the FLAG epitope and 426 bp of
upstream DNA was cloned into the EcoR1/XbaI sites of pUC19.
The resulting plasmid (pAH11) was introduced into appropriate Y.
pseudotuberculosis strains by electroporation.
To obtain fusion proteins between full-length YopK/YopK
AA
and b-lactamase lacking its N-terminal signal peptide, PCR
amplifications and standard molecular methods were performed.
First a DNA fragment corresponding to amino acids 24–286 of the
b-lactamase gene from the plasmid pTK-Hyg (Clontech Labora-
tories Inc) was cloned into the HindIII/XbaI sites of pMF353, a
modified version of the pPROLar.A expression vector (Clontech
Laboratories Inc) in which the SacI/AatII DNA fragment
containing the kanamycin resistance gene had been exchanged
for the chloramphenicol resistance gene from the pPROTet.E
vector (Clontech Laboratories Inc). Then, full length yopK or
yopK
AA sequences were PCR amplified from the plasmids pIB102
and pIB156 (described below) and cloned in frame with the b-
lactamase gene using the upstream KpnI/HindIII sites.
The Y. pseudotuberculosis yopK
AA mutant strain YPIII(pIB156) was
generated by homologous recombination. The point mutations
were obtained using an overlapping PCR strategy described in
detail elsewhere [64]. A 600 bp DNA fragment covering the yopK
T45A-D46A substitution in the center was cloned into to the
suicide vector pDM4. The T45A-D46A mutation was transferred
from the suicide vector down to the virulence plasmid by
conjugation and double cross-over performed using previously
reported methodology [65]. Similarly, to generate the Y.
pseudotuberculosis multiple yop mutant YPIII(pIB29MEKBD), the
pDM4-derived mutagenesis vector pMF024 [66] was conjugated
into YPIII(pIB29MEKB) [23] and the full length yopD deletion
introduced onto the virulence plasmid by allelic exchange.
The GST-RACK1 expression construct was generated by PCR
amplification of the RACK1 fragment from the eukaryotic
expression vector pEBG-RACK1 (kindly provided by Dr Chang
[34]) and cloned into the pGEX-4T-1vector (GE Healthcare).
Yeast two-hybrid screen
Analysis of protein–protein interactions was performed accord-
ing to the MATCHMAKER protocol (Clontech Laboratories).
The pGBT9 encoding YopK fused to the GAL4 DNA-binding
domain was transformed into Saccharomyces cerevisiae strain PJ69-4A
[67], and this strain was then used as recipient in transformations
with a pACT2-based Human HeLa MATCHMAKER cDNA
library (Clontech Laboratories). An interaction between YopK
and a protein encoded by cDNA from the HeLa cell library was
determined as growth of yeast at 30uC on minimal medium
lacking adenine, tryptophan, and leucine. To confirm that the
growth on selective plates was due to this interaction, yeast was
cured of one or both plasmids and re-assayed.
Mapping the YopK-RACK1 interaction
Different regions of the yopK gene (indicated in Figure S2A)
were amplified by PCR and cloned into the EcoRI/PstI sites of
pGBT9 (Clontech Laboratories) to create in-frame fusions
between different parts of YopK and the GAL4 DNA-binding
domain. The resulting fusions were tested for interaction with the
isolated pACT-RACK171-317 clone identified in the initial screen.
Amino acids 30–59 of YopK were identified as a RACK1-binding
region, which was further analyzed by introducing pair-wise
alanine substitutions covering aa 26–52 (indicated in Figure 1A) in
the truncated aa 7–59 form of the protein by use of a two-step
PCR strategy and synthetic oligonucleotides, as previously
described [64]. The mutations were verified by sequencing, and
all substitution mutants were subsequently tested in the yeast two-
hybrid assay for interaction with RACK1, as described above.
Detection of YopB, YopD, and YopK in erythrocyte
membranes
Contact-dependent hemolysis of sheep erythrocytes was carried
out as previously described [23,24,37,68]. Radiolabeling hemolytic
experiments were performed in TMH with 0.1 mM methionine
supplemented with
35S-labeled methionine (YopB/YopD) or
35S-
cysteine (YopK), in 2 ml reactions containing 1.5610
8 bacteria,
and 4610
9 washed sheep erythrocytes (National Veterinary
Institute Sweden). The hemolytic assay mixtures were supple-
mented with 2 mM DTT when
35S cysteine was used. Isolation of
erythrocyte plasma membranes was achieved by density centrifu-
gation as previously described [69,70] but using an additional step
involving low-intensity sonication of the bacteria-free lysate to
increase the recovery of the erythrocyte membranes. The protein
concentration of the membrane preparations was determined by
measurements at OD280 and equal amounts of purified membrane
proteins were separated by SDS-PAGE. The labeled proteins were
visualized by exposing dried Coomassie-stained gels on a storage
phosphor screen (Molecular Dynamics) and then developing in a
Storm 860 imaging system (Molecular Dynamics). The proteins
were quantified using the Quantity One software package (Bio-
Rad). The presence of the proteins was further verified by Western
blot analysis of separated membrane fractions.
Cell lines
HeLa cells (DSMZ) were maintained in Minimum Essential
Medium (MEM) (Sigma) supplemented with 10% fetal calf serum
(PromoCell), 2 mM GlutaMAX
TM-I (Invitrogen), 100 U/ml
penicillin, and 100 mg/ml streptomycin (Invitrogen). For virus
production, human 293FT cells (Invitrogen) were maintained in
Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco) supple-
mented with 10% fetal bovine serum (Invitrogen), 0.1 mM MEM
Non-Essential Amino Acids (Invitrogen), and 500 mg/ml Genet-
icinH (Invitrogen). All cell lines were cultivated at 37uCi na
humidified atmosphere containing 5% CO2. For experiments
using 12-mm coverslips, 2.5610
4 HeLa cells were seeded one day
before infection.
RACK1 RNAi cells were generated using the BLOCK-iT
TM
Inducible H1 Lentiviral RNAi System (Invitrogen) according to
the manufacturer’s instructions and then cultivated as described
above. For the RACK1 RNAi two different target sequences were
used: RACK1 RNAi 1 (start at 275): GGGTCACTCCCACT-
TTGTTAG and RACK1 RNAi 2 (start at 751): GGGATCT-
CAACGAAGGCAAAC.
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shRNA were selected using 100 mg/ml Zeocin
TM (Invitrogen).
Individual clones were isolated and expanded, and cellular
RACK1 levels were analyzed by Western blot.
Antibodies
The following primary antibodies were used: mouse anti-human
RACK1 (clone 20), mouse anti-human Erk (clone 16), mouse anti-
human Ras (clone 18) (BD Transduction Laboratories); mouse
anti-FLAG pre-coupled to beads (clone M2) (Sigma) rabbit anti-
Yersinia, anti-YopK, anti-YopD, anti-YopB, anti-YopE, anti-Ail
and anti-LcrV antisera (Agrisera, Sweden); mouse anti-human
Tubulin (clone B-5-1-2) (Sigma). The following secondary
antibodies were used: Alexa488 goat anti-mouse IgM, Alexa488
donkey anti-rabbit, and Alexa555 goat anti-rabbit (Molecular
Probes, Invitrogen); HRP goat anti-mouse IgM (Invitrogen); HRP
donkey anti-rabbit (GE Healthcare); HRP goat anti-mouse
(DAKO).
b-lactamase assay for determination of translocated
YopK
One day before infection, HeLa cells were seeded on glass
coverslips in a 24-well plate, and cytochalasin D (0.5 mg/ml) was
added to the cells 30 min before infection to prevent bacterial
internalization. Overnight cultures of Y. pseudotuberculosis yopK
mutant [YPIII(pIB155)] and yopB mutant [YPIII(pIB604)] strains
expressing YopK-blac or YopK
AA-blac were diluted in fresh
MEM and induced for Yop expression. HeLa cells were infected at
a multiplicity of infection (MOI) of 20 for 3 hr. For microscopy,
the FRET-based fluorescent b-lactamase substrate CCF2-AM
(Invitrogen) was prepared according to the manufacturer’s
instructions and added directly to the cells. Cells were incubated
for 1 hr in the dark at room temperature and then washed twice,
fixed, and mounted using ultimate mounting medium (UMM)
[46]. Samples were analyzed by fluorescence microscopy (Zeiss
Axioskop), and images were captured using a CCD camera
(Hamamatsu Orca C4742-95). The HeLa cells appeared green if
there had been no translocation of Yop–b-lactamase fusions,
whereas they were blue if they contained such fusions in their
cytoplasm.
Co-purification and co-precipitation
For YopD co-purification, 200 ml of Y. pseudotuberculosis
YPIII(pIB29MEKByopD::His) encoding His-yopD and YPIII
(pIB29MEKBD), both harbouring the yopK encoding pAH3
plasmid, were grown for 2.5 h in secretion permissive conditions
in LB at 37uC. The cells were harvested and supernatants were
filtered through a 45 mm SFCA filtering device (Nalgene).
Additions were made to the cleared supernatants giving a final
concentration of 20 mM Tris-HCl pH 7.4, 250 mM NaCl,
60 mM Imidazole, 10 mM MgCl2, and 5 mM CaCl2. The
supernatants were passed through a 5 ml His-Trap FF column
(GE Healthcare), washed with a buffer containing 20 mM Tris-
HCl pH 7.4, 250 mM NaCl, 60 mM Imidazole 5 mM MgCl2,
and 1 mM CaCl2, and eluted with a similar buffer containing
500 mM Imidazole. The final samples were analyzed using
Western blot.
For YopK pulldown of proteins in bacterial supernatant,
overnight cultures of Y. pseudotuberculosis yopK mutant [YPIII
(pIB155)] and yopK mutant expressing YopK-FLAG [YPIII
(pIB155, pAH11)] were diluted 1:10 and grown in secretion
permissive conditions in fresh BHI medium at 37uC. After
centrifugation, the resulting culture supernatants were collected
and incubated with beads coupled to anti-FLAG antibodies for
45 min at room temperature. The beads were subsequently
collected by centrifugation and washed with RIPA buffer
containing protease inhibitor (Roche). For detection of interaction
of YopK–FLAG with proteins present in the bacterial supernatant,
samples were analysed by SDS-PAGE and Western blot.
For YopK pulldown of proteins in Hela cell lysates a 10-ml
portion of anti-FLAG beads was preincubated with 200 mlo f
culture supernatants from Y. pseudotuberculosis multiple yop mutant
strain (YPIII(pIB29MEKBD) expressing or not expressing YopK-
FLAG (grown as described above). The beads were thereafter
washed and incubated with 120 ml of cleared HeLa cell lysate
(3610
6 cells) for 45 min at room temperature. For reciprocal pull
down experiments using purified recombinant RACK1, GST
(pGEX-4T-1) and GST-RACK1 (pGEX-RACK1) were expressed
in E. coli (BL21; Stratagene) and purified by standard methods
recommended by the manufacturer (GE Healthcare). GST and
GST-RACK1 on glutathione sepharose beads (GE healthcare)
were washed with RIPA buffer containing protease inhibitor
(Roche) and then incubated for 45 min at room temperature with
a culture supernatant from Y. pseudotuberculosis multiple mutant
expressing YopK-FLAG [YPIII(pIB29MEKBD, pAH11]. The
different pull-down samples were centrifuged through a gradient
(300 ml RIPA, 300 ml 17% glycerol in RIPA, 300 ml 27% sucrose/
17% glycerol mixture in RIPA) for 1 min at 14 000 rpm. The
pelleted material was boiled in sample buffer and separated by
SDS-PAGE. Co-precipitation of RACK1 with YopK–FLAG and
co-precipitation of YopK with GST-RACK1 was detected by
Western blot.
Animal infection and measurement of In Vivo
bioluminescence
Eight-week-old female BALB/c mice (Scanbur, Denmark) were
divided into three groups with five animals in each and then orally
infected with Y. pseudotuberculosis wild-type (YPII/pCD1-Xen4),
yopK null [YPIII(pCD155-Xen4)], or yopK
AA [YPIII(pCD156-
Xen4)]. The mice were deprived of food and water for 18 hr
before oral infection. The Yersinia strains were grown overnight in
LB at 26uC and subsequently resuspended in sterile tap water
supplemented with 150 mM NaCl. The infection dose was
determined by viable count and drinking volume measurements.
The animals were inspected daily for signs of disease, and they
were analyzed for light emission in an IVIS Spectrum (Caliper Life
Sciences) on days 3, 8, 10, and 13 of infection. Prior to imaging,
the mice were anesthetized with 2.5% isoflurane (IsoFluHVet,
Orion Pharma Animal Health, Sweden) mixed with oxygen
supplied from an XG1-8 gas system (Caliper Life Sciences).
Images were acquired and analyzed using LivingImage software
(Caliper Life Sciences). Total photon emission was recorded for
each animal, and the light emitted from each individual mouse
was quantified using the Region of Interest (ROI) tool.
Determination of bacterial uptake
The Y. pseudotuberculosis strains were grown in LB over night at
26uC. For infection, bacteria were diluted in MEM and induced
for Yop expression. HeLa cells (2.5610
4) were seeded on 12-mm
glass coverslips the day before the experiment, and they were
infected with a multiplicity of infection (MOI) of 20 for 30 min at
37uC in a humidified atmosphere containing 5% CO2. Intracel-
lularly and extracellularly located bacteria were distinguished by
using a previously described double-fluorescent labeling method
[71,72]. Samples were analyzed by fluorescence microscopy (Zeiss
Axioskop). Numbers of extracellularly bound and total cell-
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coverslip.
Determination of effector translocation
Effector translocation was determined using a method based on
the ability of Pseudomonas aeruginosa effector ExoS to modify
eukaryotic Ras in infected cells [73]. For this, the Y. pseudotuber-
culosis yopE mutant strain expressing ExoS in trans [YPIII(pIB526),
pTS103] was employed. A YopE defective background was chosen
for this assay in order to avoid a repressing effect on pore
formation and thereby influence of ExoS translocation efficiency
[74]. Modification of Ras was visualized by Western blot. Protease
protection and digitonin extraction of translocated Yersinia effector
proteins were carried out as described elsewhere [49,75].
Translocation of bacterial proteins was scored as the difference
between YopE levels in digitonin-treated and untreated HeLa cells
analyzed by Western blot.
Cytotoxicity assay
HeLa cells were seeded on coverslips the day before infection.
Overnight cultures of Yersinia strains were diluted in fresh MEM
and induced for Yop expression. HeLa cells were infected with a
multiplicity of infection (MOI) of 10–20 for 1 hr and were
subsequently fixed with 2% PFA, washed in PBS, and the
coverslips were mounted with MowiolH (Calbiochem). Cytotoxic-
ity (cell rounding) was assessed by microscopy as previously
described [14].
Immunofluorescence
HeLa cells were infected with Yersinia or subjected to a cell-
spreading assay [47]. Thereafter cells were washed, fixed with 4%
PFA, and permeabilized with 0.5% Triton X-100. To block non-
specific binding, the specimens were overlaid with 0.1 M glycine
followed by 5% serum from the secondary antibody host. The
different samples were stained with indicated antibodies. The
specimens were mounted in ultimate mounting medium (UMM)
[46] supplemented with Citifluor (Ted Pella Inc.) or in MowiolH
(Calbiochem) and examined by fluorescence microscopy
(Zeiss Axioskop) or confocal laser scanning microscopy (Leica
instrument).
Supporting Information
Figure S1 Bacterial proteins in purified erythrocyte
membranes after infection with Y. pseudotuberculosis.
Western blot control showing presence of YopD and YopB, but
not LcrV or the bacterial outer membrane protein Ail, in the
membrane fraction from erythrocytes infected with the Y.
pseudotuberculosis wild-type strain.
(TIF)
Figure S2 Mapping and characterization of the YopK–
RACK1 interaction. (A) Determination of interaction between
different regions of the RACK1 protein and YopK7-59 and
YopK
AA
7-59 respectively, using the yeast two-hybrid system as a
read-out. pACTcDNA3 encodes the RACK1 fragment identified
as a YopK-interacting protein in the initial yeast two hybrid
screen. In the diagram, +++ indicates growth corresponding to
that seen in strains with non-mutated YopK and RACK1, and –
stands for no growth. (B) Determination of interaction between
RACK1 and different regions of the YopK protein using the yeast
two-hybrid system as a read-out. In the diagram, +++, ++, + and –
correspond to degree of growth, where +++ indicate the most
pronounced growth and – stands for no growth. (C) Determination
of Yop translocation capacity of Y. pseudotuberculosis yopK mutants.
HeLa cells were infected with the indicated strains and then
treated with proteinase K. Thereafter, the cells were washed and
lysed with digitonin or left untreated, whereafter the supernatants
were subjected to SDS-PAGE and immunoblotted for YopE. The
translocation deficient yopD mutant was included as negative
control.
(TIF)
Figure S3 Internalization of Y. pseudotuberculosis
strains by RACK1 RNAi cell lines. (A) Internalization of
the indicated Y. pseudotuberculosis strains by HeLa control cells and
two RACK1 RNAi cell lines obtained using oligos directed
towards two different RACK1 target sequences. The number of
internalized bacteria is presented as percent of the total number of
cell-associated bacteria. The illustrated data represent the mean 6
SEM of three independent experiments. (B) Internalization of the
indicated Y. pseudotuberculosis strains by HeLa control cells and the
indicated RACK1 RNAi cell lines. The number of internalized
bacteria is presented as percent of the total number of cell-
associated bacteria. The illustrated data represent the mean 6
SEM of at least three independent experiments. P,0.05 *. Inset
Downregulation of RACK1 expression in HeLa cells by RNAi.
Lysates of HeLa control cells and different RACK1 RNAi clones
were analyzed for RACK1 expression by Western blot using anti-
RACK1 antibodies. The levels of RACK1 in the different RNAi
cell lines are presented as expression relative to that observed in
the HeLa control cells.
(TIF)
Figure S4 Localization of RACK1 in cultured HeLa cells.
Localization of RACK1 in HeLa cells in culture was revealed by
staining for RACK1 and analyzing by confocal microscopy.
(TIF)
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